Alumni raised $1.45B in 2022 - Download Free Report Now

Intersect ENT (fka Sinexus)

Bioabsorbable drug-eluting stent for chronic sinusitis patients.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Intersect ENT (fka Sinexus) plus 5521 other startups.

Start Free 7 Day Trial Now

Learn More About Intersect ENT (fka Sinexus)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With